201 related articles for article (PubMed ID: 16957559)
1. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
4. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
5. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
[TBL] [Abstract][Full Text] [Related]
6. Effects of MCI-154 on vascular reactivity and its mechanisms after hemorrhagic shock in rats.
Yang G; Liu L; Xu J; Li T
J Cardiovasc Pharmacol; 2006 Jun; 47(6):751-7. PubMed ID: 16810075
[TBL] [Abstract][Full Text] [Related]
7. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.
Lu C; Su LY; Lee RM; Gao YJ
Eur J Pharmacol; 2008 Jul; 589(1-3):188-93. PubMed ID: 18538762
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.
Budzyn K; Marley PD; Sobey CG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1248-53. PubMed ID: 15743931
[TBL] [Abstract][Full Text] [Related]
9. Effect of arginine vasopressin on vascular reactivity and calcium sensitivity after hemorrhagic shock in rats and its relationship to Rho-kinase.
Yang G; Liu L; Xu J; Li T
J Trauma; 2006 Dec; 61(6):1336-42. PubMed ID: 17159674
[TBL] [Abstract][Full Text] [Related]
10. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
11. Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase.
Zhu Z; Zhu S; Liu D; Cao T; Wang L; Tepel M
Hypertension; 2005 Feb; 45(2):233-9. PubMed ID: 15611360
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
13. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
14. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats.
Dubinion JH; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1330-6. PubMed ID: 16537795
[TBL] [Abstract][Full Text] [Related]
15. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.
Löhn M; Steioff K; Bleich M; Busch AE; Ivashchenko Y
Eur J Pharmacol; 2005 Jan; 507(1-3):179-86. PubMed ID: 15659308
[TBL] [Abstract][Full Text] [Related]
17. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
Han YJ; Hu WY; Piano M; de Lanerolle P
Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
[TBL] [Abstract][Full Text] [Related]
18. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
Jalil J; Lavandero S; Chiong M; Ocaranza MP
Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats.
Rodríguez A; Frühbeck G; Gómez-Ambrosi J; Catalán V; Sáinz N; Díez J; Zalba G; Fortuño A
J Hypertens; 2006 Aug; 24(8):1589-97. PubMed ID: 16877962
[TBL] [Abstract][Full Text] [Related]
20. Heat shock-induced augmentation of vascular contractility is independent of rho-kinase.
Seok Y; Kim JI; Ito M; Kureishi Y; Nakano T; Kim SO; Lim DG; Park WH; Kim I
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):264-8. PubMed ID: 16487272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]